Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | APLNR | P35414 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27525501 | 0.98 | THRB (0.35) | THRBCYP2C9HSD11B1EPHX1EPHX2 | |
| Bromide SCHEMBL27511892 | 0.98 | THRB (0.35) | THRBCYP2C9HSD11B1EPHX1EPHX2 | |
| SCHEMBL4711516 | 0.88 | THRB (0.34) | THRBCYP2C9HSD11B1EPHX1EPHX2 | |
| SCHEMBL31084441 | 0.83 | MAPK1 (0.36) | THRBCYP2C9HSD11B1EPHX1EPHX2 | |
| SCHEMBL6860976 | 0.83 | GAA (0.38) | THRBCYP2C9HSD11B1EPHX1EPHX2 | |
| SCHEMBL2849062 | 0.81 | ALDH1A1 (0.39) | THRBCYP2C9EPHX1EPHX2ALDH1A1 | |
| SCHEMBL6854374 | 0.81 | EPHX1 (0.34) | THRBCYP2C9HSD11B1EPHX1EPHX2 | |
| Hydrochloric Acid SCHEMBL11330577 | 0.80 | THRB (0.40) | THRBCYP2C9EPHX1ALDH1A1 | |
| SCHEMBL4582380 | 0.78 | EPHX2 (0.40) | THRBCYP2C9HSD11B1EPHX1EPHX2 | |
| SCHEMBL28699821 | 0.78 | THRB (0.36) | THRBCYP2C9HSD11B1EPHX1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109641962-A | anti-B7-H3 antibodies and antibody drug conjugates | 艾伯维公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-109562168-A | anti-CD 98 antibodies and antibody drug conjugates | 艾伯维公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109562190-A | ANTI-EGFR ANTIBODY DRUG CONJUGATES | 艾伯维公司 | 2019-04-02 | — | — | CN | disclosed |
| WO-2017201581-A1 | NON-TOXIC IRON CHELATORS WITH NEUROPROTECTIVE POTENTIAL | THE UNIVERSITY OF SYDNEY (AU) | 2017-11-30 | — | — | WO | disclosed |
| US-20120318969-A1 | METHOD FOR THE DIFFERENTIATION OF ALTERNATIVE SOURCES OF NAPHTHENIC ACIDS | UNIVERSITY OF PLYMOUTH (GB) | 2012-12-20 | — | — | US | disclosed |
| EP-1861384-A1 | 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS | Sterix Limited (GB) | 2007-12-05 | — | — | EP | disclosed |
| CN-1308338-C | Phosphorus compound | DAICEL CHEM (JP) | 2007-04-04 | — | — | CN | disclosed |
| WO-2006100502-A1 | 11-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS | STERIX LIMITED (GB) | 2006-09-28 | — | — | WO | disclosed |
| CN-1224625-C | Phosphorus-containing compound | DAICEL CHEM (JP) | 2005-10-26 | — | — | CN | disclosed |
| CN-1597686-A | Phosphorus compound | DAICEL CHEM (JP) | 2005-03-23 | — | — | CN | disclosed |
| US-6794528-B2 | HEAT RESISTANCE, FLAME RETARDERS, STABILIZERS; REACTING DIALCOHOL COMPOUND WITH A PHOSPHYL OXYCHLORIDE COMPOUND | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-09-21 | — | — | US | disclosed |
| US-20030109736-A1 | Phosphorus compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-06-12 | — | — | US | disclosed |
| EP-1277758-A1 | PHOSPHORUS COMPOUND | Daicel Chemical Industries, Ltd. (JP) | 2003-01-22 | — | — | EP | disclosed |
| CN-1383429-A | Phosphorus-containing compound | DAICEL CHEM (JP) | 2002-12-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109736-A1 | Phosphorus compound | NR4A1, POLL, NR0B1 | THRB 1241/4885CYP2C9 3141/4885HSD11B1 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.